Skip to main content

Table 1 H and EH disease rates of the R and NR groups.

From: Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors

No of patients (%)

R

NR

H

30(69%)

11(31%)

EH

13(31%)

24(69%)